Proteomics in Thyroid Tumor Research
Authors:
Open Access
- 1 August 2009
- journal article
- review article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 94 (8) , 2717-2724
Abstract
Background: In recent years, “OMICS” technologies have paved novel ways for the broad-scale identification of molecular signatures and signaling pathways specific to tumorigenesis. Related to this are high hopes for the discovery of biomarkers facilitating diagnosis and prognosis of cancer as well as the option for pathway-targeted tumor treatment. Among the different OMICS methods, the potential of proteomics is just beginning to emerge, and according to the current literature, the proteome is to date the most feasible tool to reflect tumor biology. Objective: In this review we discuss the application of proteomics to the field of thyroid tumor research. Context: First, we provide an overview of different methods for protein expression profiling and then discuss specific requirements and challenges of thyroid proteomics. Furthermore, we summarize results of published proteomics studies on human thyroid tumors and finally explore perspectives of thyroid proteomics, which, combined with mRNA expression profiling and traditional biochemical methods, is increasingly contributing to an improved understanding of thyroid tumorigenesis and may in the future open novel avenues in thyroid cancer therapy.Keywords
This publication has 49 references indexed in Scilit:
- Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancerLung Cancer, 2009
- Proteomic studies of early-stage and advanced ovarian cancer patientsGynecologic Oncology, 2008
- Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expressionBreast Cancer Research, 2008
- Identification of Lung Cancer Patients by Serum Protein Profiling Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass SpectrometryAmerican Journal of Clinical Oncology, 2008
- Uncommon Mutation, but Common Amplifications, of thePIK3CAGene in Thyroid TumorsThe Journal of Clinical Endocrinology & Metabolism, 2005
- The Thyroid NoduleNew England Journal of Medicine, 2004
- Proteomic analysis of cellular signalingExpert Review of Proteomics, 2004
- Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery ToolMolecular & Cellular Proteomics, 2004
- RASPoint Mutations and PAX8-PPARγ Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2003
- Controversies in the management of cold, hot, and occult thyroid nodulesThe American Journal of Medicine, 1995